Global Digital Therapeutics for Endocrine System Diseases Market Research Report 2023

Digital Therapeutics for Endocrine System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent endocrine system diseases.

The global Digital Therapeutics for Endocrine System Diseases market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Digital Therapeutics for Endocrine System Diseases is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Digital Therapeutics for Endocrine System Diseases in Diabetes is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Digital Therapeutics for Endocrine System Diseases include Livongo, SHANGYI and EnteroMedics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Endocrine System Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Endocrine System Diseases.

The Digital Therapeutics for Endocrine System Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Digital Therapeutics for Endocrine System Diseases market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Digital Therapeutics for Endocrine System Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Prevention

1.2.3 Management

1.2.4 Treatment

1.3 Market by Application

1.3.1 Global Digital Therapeutics for Endocrine System Diseases Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Diabetes

1.3.3 Metabolic Syndrome

1.3.4 Obesity

1.3.5 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Digital Therapeutics for Endocrine System Diseases Market Perspective (2018-2029)

2.2 Digital Therapeutics for Endocrine System Diseases Growth Trends by Region

2.2.1 Global Digital Therapeutics for Endocrine System Diseases Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Digital Therapeutics for Endocrine System Diseases Historic Market Size by Region (2018-2023)

2.2.3 Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2024-2029)

2.3 Digital Therapeutics for Endocrine System Diseases Market Dynamics

2.3.1 Digital Therapeutics for Endocrine System Diseases Industry Trends

2.3.2 Digital Therapeutics for Endocrine System Diseases Market Drivers

2.3.3 Digital Therapeutics for Endocrine System Diseases Market Challenges

2.3.4 Digital Therapeutics for Endocrine System Diseases Market Restraints

3.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue

3.1.1 Global Top Digital Therapeutics for Endocrine System Diseases Players by Revenue (2018-2023)

3.1.2 Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Players (2018-2023)

3.2 Global Digital Therapeutics for Endocrine System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Digital Therapeutics for Endocrine System Diseases Revenue

3.4 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio

3.4.1 Global Digital Therapeutics for Endocrine System Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Endocrine System Diseases Revenue in 2022

3.5 Digital Therapeutics for Endocrine System Diseases Key Players Head office and Area Served

3.6 Key Players Digital Therapeutics for Endocrine System Diseases Product Solution and Service

3.7 Date of Enter into Digital Therapeutics for Endocrine System Diseases Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Type (2018-2023)

4.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2024-2029)

5.1 Global Digital Therapeutics for Endocrine System Diseases Historic Market Size by Application (2018-2023)

5.2 Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2024-2029)

6.1 North America Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)

6.2 North America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023)

6.4 North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)

7.2 Europe Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023)

7.4 Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)

8.2 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2018-2023)

8.4 Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)

9.2 Latin America Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023)

9.4 Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size (2018-2029)

10.2 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023)

10.4 Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Livongo

11.1.1 Livongo Company Detail

11.1.2 Livongo Business Overview

11.1.3 Livongo Digital Therapeutics for Endocrine System Diseases Introduction

11.1.4 Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

11.1.5 Livongo Recent Development

11.2 SHANGYI

11.2.1 SHANGYI Company Detail

11.2.2 SHANGYI Business Overview

11.2.3 SHANGYI Digital Therapeutics for Endocrine System Diseases Introduction

11.2.4 SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

11.2.5 SHANGYI Recent Development

11.3 EnteroMedics

11.3.1 EnteroMedics Company Detail

11.3.2 EnteroMedics Business Overview

11.3.3 EnteroMedics Digital Therapeutics for Endocrine System Diseases Introduction

11.3.4 EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

11.3.5 EnteroMedics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Prevention

    Table 3. Key Players of Management

    Table 4. Key Players of Treatment

    Table 5. Global Digital Therapeutics for Endocrine System Diseases Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Digital Therapeutics for Endocrine System Diseases Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2018-2023)

    Table 9. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region (2024-2029)

    Table 11. Digital Therapeutics for Endocrine System Diseases Market Trends

    Table 12. Digital Therapeutics for Endocrine System Diseases Market Drivers

    Table 13. Digital Therapeutics for Endocrine System Diseases Market Challenges

    Table 14. Digital Therapeutics for Endocrine System Diseases Market Restraints

    Table 15. Global Digital Therapeutics for Endocrine System Diseases Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players (2018-2023)

    Table 17. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2022)

    Table 18. Ranking of Global Top Digital Therapeutics for Endocrine System Diseases Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Digital Therapeutics for Endocrine System Diseases Product Solution and Service

    Table 22. Date of Enter into Digital Therapeutics for Endocrine System Diseases Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Digital Therapeutics for Endocrine System Diseases Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2018-2023)

    Table 26. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Type (2024-2029)

    Table 28. Global Digital Therapeutics for Endocrine System Diseases Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2018-2023)

    Table 30. Global Digital Therapeutics for Endocrine System Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Digital Therapeutics for Endocrine System Diseases Revenue Market Share by Application (2024-2029)

    Table 32. North America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Livongo Company Detail

    Table 48. Livongo Business Overview

    Table 49. Livongo Digital Therapeutics for Endocrine System Diseases Product

    Table 50. Livongo Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023) & (US$ Million)

    Table 51. Livongo Recent Development

    Table 52. SHANGYI Company Detail

    Table 53. SHANGYI Business Overview

    Table 54. SHANGYI Digital Therapeutics for Endocrine System Diseases Product

    Table 55. SHANGYI Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023) & (US$ Million)

    Table 56. SHANGYI Recent Development

    Table 57. EnteroMedics Company Detail

    Table 58. EnteroMedics Business Overview

    Table 59. EnteroMedics Digital Therapeutics for Endocrine System Diseases Product

    Table 60. EnteroMedics Revenue in Digital Therapeutics for Endocrine System Diseases Business (2018-2023) & (US$ Million)

    Table 61. EnteroMedics Recent Development

    Table 62. Research Programs/Design for This Report

    Table 63. Key Data Information from Secondary Sources

    Table 64. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Digital Therapeutics for Endocrine System Diseases Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Digital Therapeutics for Endocrine System Diseases Market Share by Type: 2022 VS 2029

    Figure 3. Prevention Features

    Figure 4. Management Features

    Figure 5. Treatment Features

    Figure 6. Global Digital Therapeutics for Endocrine System Diseases Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Digital Therapeutics for Endocrine System Diseases Market Share by Application: 2022 VS 2029

    Figure 8. Diabetes Case Studies

    Figure 9. Metabolic Syndrome Case Studies

    Figure 10. Obesity Case Studies

    Figure 11. Other Case Studies

    Figure 12. Digital Therapeutics for Endocrine System Diseases Report Years Considered

    Figure 13. Global Digital Therapeutics for Endocrine System Diseases Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Digital Therapeutics for Endocrine System Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Digital Therapeutics for Endocrine System Diseases Market Share by Region: 2022 VS 2029

    Figure 16. Global Digital Therapeutics for Endocrine System Diseases Market Share by Players in 2022

    Figure 17. Global Top Digital Therapeutics for Endocrine System Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Endocrine System Diseases as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Digital Therapeutics for Endocrine System Diseases Revenue in 2022

    Figure 19. North America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2018-2029)

    Figure 21. United States Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Digital Therapeutics for Endocrine System Diseases Market Share by Country (2018-2029)

    Figure 25. Germany Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Digital Therapeutics for Endocrine System Diseases Market Share by Region (2018-2029)

    Figure 33. China Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Digital Therapeutics for Endocrine System Diseases Market Share by Country (2018-2029)

    Figure 41. Mexico Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Digital Therapeutics for Endocrine System Diseases Market Share by Country (2018-2029)

    Figure 45. Turkey Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Digital Therapeutics for Endocrine System Diseases Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Livongo Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

    Figure 48. SHANGYI Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

    Figure 49. EnteroMedics Revenue Growth Rate in Digital Therapeutics for Endocrine System Diseases Business (2018-2023)

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed